House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Orthopaedics

Detection and Non-Operative Management of Pediatric Developmental Dysplasia of the Hip

AAOS · 2022 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

This AAOS update addresses detection and nonoperative management of developmental hip dysplasia in infants up to six months. It favors selective imaging for important risk factors, repeated clinical examinations after an initially normal screen and individualized observation or bracing. A stable hip with an ultrasound abnormality is treated as a different decision from a clinically unstable hip. Several treatment and surveillance choices rest on limited evidence, which is retained explicitly here.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Use selective imaging and repeat clinical examination

  • Do not perform universal ultrasound screening of all newborns for developmental dysplasia of the hip. AAOS supports this recommendation with moderate evidence; this does not remove the need for risk-based imaging or clinical surveillance. [1]
  • Obtain a hip imaging study before 6 months of age when there is breech presentation, family history or a history of clinical instability. The updated recommendation is strong and applies when at least one of these risk factors is present. [1]
  • Re-examine the hips at subsequent visits before 6 months even after a normal initial hip examination. This surveillance recommendation has moderate evidence; the guideline does not establish an optimal frequency. [1]

Match imaging to age and the clinical examination

  • For an infant younger than 6 weeks with a positive instability examination, ultrasound may help decide whether to start bracing. This is supported by limited evidence and is a decision aid rather than a mandate to delay necessary treatment. [1]
  • From 4 months of age, an anteroposterior pelvic radiograph may be used instead of ultrasound to assess dysplasia. Evidence is limited, and radiography entails ionizing-radiation exposure. [1]
  • For breech presentation or family history despite a normal examination, the rationale supports selective ultrasound at 2–6 weeks or an AP pelvic radiograph at 4 months. It also acknowledges that the optimal imaging age is not established; these are supported approaches rather than a uniquely proven schedule. [1]

Distinguish stable imaging abnormalities from instability

  • Observation without a brace is an option for an infant whose hip is clinically stable but has morphological ultrasound abnormalities. Evidence is limited; surveillance matters because observation can delay treatment when treatment is actually needed. [1]
  • For a positive instability examination, limited evidence supports either immediate bracing or delayed bracing at 2–9 weeks. The evidence comparing these approaches does not adequately distinguish dislocated from dislocatable hips, so it does not justify a uniform delay for every unstable hip. [1]
  • For initial treatment of an unstable hip, AAOS gives moderate-evidence support to the von Rosen splint over Pavlik, Craig or Frejka splints. This comparison concerns the braces studied and does not establish equivalence for every other fixed-position device. [1]

Reassess during bracing and account for harm

  • During brace treatment for an unstable infant hip, perform serial physical examinations and periodic age-appropriate ultrasound or radiographs. Evidence is limited, and the studies do not define a best imaging interval. [1]
  • Use follow-up findings to reconsider the treatment plan when reduction fails or dysplasia persists. Include potential avascular necrosis and skin irritation in the assessment of bracing harms; the relative avascular-necrosis risk between rigid and soft braces is unknown. [1]

Limitations and use

  • The guideline is confined to infants up to six months and does not provide a surgical pathway, a complete brace-fitting prescription or management of older children.
  • Optimal surveillance frequency, imaging intervals and the best timing of treatment are not established for every clinical subgroup. The immediate-versus-delayed bracing evidence does not adequately separate dislocated from dislocatable hips.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Detection and Non-Operative Management of Pediatric Developmental Dysplasia of the Hip

    Selected recommendation material consulted

Clinical practice guideline

Publication details

Issuing organisation
AAOS
Resource type
Clinical practice guideline · House clinical summary
Source setting
United States

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Use selective imaging and repeat clinical examination
  • Match imaging to age and the clinical examination
  • Distinguish stable imaging abnormalities from instability
  • Reassess during bracing and account for harm
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House